title: Growth pattern of colorectal liver metastasis as a marker of recurrence risk.
abstract: Despite improved therapy of advanced colorectal cancer, the median overall survival (OS) is still low. A surgical removal has significantly improved survival, if lesions are entirely removed. The purpose of this retrospective explorative study was to evaluate the prognostic value of histological growth patterns (GP) in chemonaive and patients receiving neo-adjuvant therapy. Two-hundred-fifty-four patients who underwent liver resection of colorectal liver metastases between 2007 and 2011 were included in the study. Clinicopathological data and information on neo-adjuvant treatment were retrieved from patient and pathology records. Histological GP were evaluated and related to recurrence free and OS. Kaplan-Meier curves, log-rank test and Cox regression analysis were used. The 5-year OS was 41.8% (95% CI 33.8-49.8%). Growth pattern evaluation of the largest liver metastasis was possible in 224 cases, with the following distribution: desmoplastic 63 patients (28.1%); pushing 77 patients (34.4%); replacement 28 patients (12.5%); mixed 56 patients (25.0%). The Kaplan-Meier analyses demonstrated that patients resected for liver metastases with desmoplastic growth pattern had a longer recurrence free survival (RFS) than patients resected for non-desmoplastic liver metastases (p=0.05). When patients were stratified according to neo-adjuvant treatment in the multivariate Cox regression model, hazard ratios for RFS compared to desmoplastic were: pushing (HR=1.37, 95% CI 0.93-2.02, p=0.116), replacement (HR=2.16, 95% CI 1.29-3.62, p=0.003) and mixed (HR=1.70, 95% CI 1.12-2.59, p=0.013). This was true for chemonaive patients as well as for patients who received neo-adjuvant treatment.
authors.affiliation: The Finsen Laboratory, Rigshospitalet, Ole Maaleoes Vej 5, Building 3, 3rd Floor, 2200, Copenhagen, Denmark, rikke.loevendahl.eefsen@regionh.dk.
authors.forename: R L
authors.initials: RL
authors.lastname: Eefsen
authors.forename: P B
authors.initials: PB
authors.lastname: Vermeulen
authors.forename: I J
authors.initials: IJ
authors.lastname: Christensen
authors.forename: O D
authors.initials: OD
authors.lastname: Laerum
authors.forename: M B
authors.initials: MB
authors.lastname: Mogensen
authors.forename: H C
authors.initials: HC
authors.lastname: Rolff
authors.forename: G G
authors.initials: GG
authors.lastname: Van den Eynden
authors.forename: G
authors.initials: G
authors.lastname: Høyer-Hansen
authors.forename: K
authors.initials: K
authors.lastname: Osterlind
authors.forename: B
authors.initials: B
authors.lastname: Vainer
authors.forename: M
authors.initials: M
authors.lastname: Illemann
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D049109:Cell Proliferation; D015179:Colorectal Neoplasms / Q000473:pathology*; D003131:Combined Modality Therapy; D058405:Desmoplastic Small Round Cell Tumor / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008099:Liver / Q000473:pathology / Q000601:surgery; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000601:surgery; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D055815:Young Adult
references.citation: Ann Surg Oncol. 2007 Feb;14(2):786-94
references.pmid: 17103254
references.citation: Recent Results Cancer Res. 2014;203:243-52
references.pmid: 25103010
references.citation: Int J Cancer. 2009 Apr 15;124(8):1860-70
references.pmid: 19123477
references.citation: Am J Surg. 2014 Apr;207(4):493-8
references.pmid: 24112674
references.citation: Dig Surg. 1999;16(6):459-67
references.pmid: 10805544
references.citation: Lancet Oncol. 2013 Nov;14(12):1208-15
references.pmid: 24120480
references.citation: World J Surg Oncol. 2014 Apr 27;12:127
references.pmid: 24767422
references.citation: J Clin Oncol. 2008 Apr 20;26(12):2013-9
references.pmid: 18421054
references.citation: PLoS Med. 2012;9(5):e1001216
references.pmid: 22675273
references.citation: Ann Oncol. 2002 Feb;13(2):308-17
references.pmid: 11886010
references.citation: HPB (Oxford). 2009 Sep;11(6):499-504
references.pmid: 19816614
references.citation: N Engl J Med. 2004 Jun 3;350(23 ):2335-42
references.pmid: 15175435
references.citation: Hum Pathol. 1982 Jun;13(6):563-8
references.pmid: 6176525
references.citation: J Natl Cancer Inst. 2007 Jul 4;99(13):998-1003
references.pmid: 17596575
references.citation: Am J Gastroenterol. 1999 Mar;94(3):739-43
references.pmid: 10086660
references.citation: Ann Surg. 2005 May;241(5):715-22, discussion 722-4
references.pmid: 15849507
references.citation: Ann Oncol. 2005 Aug;16(8):1311-9
references.pmid: 15870084
references.citation: Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
references.pmid: 25190710
references.citation: Ann Surg. 2002 Jun;235(6):759-66
references.pmid: 12035031
references.citation: Clin Exp Metastasis. 2012 Aug;29(6):541-9
references.pmid: 22476470
references.citation: Lancet. 2008 Mar 22;371(9617):1007-16
references.pmid: 18358928
references.citation: Ann Surg Oncol. 2012 Sep;19(9):2860-8
references.pmid: 22526903
references.citation: Br J Cancer. 2004 Apr 5;90(7):1429-36
references.pmid: 15054467
references.citation: Ann Surg. 2006 Aug;244(2):254-9
references.pmid: 16858188
references.citation: JAMA Ophthalmol. 2013 Apr;131(4):462-9
references.pmid: 23392528
references.citation: Jpn J Clin Oncol. 1996 Feb;26(1):24-9
references.pmid: 8551663
references.citation: Zentralbl Chir. 2014 Apr;139(2):220-5
references.pmid: 23846535
references.citation: Cancer. 2000 Jul 15;89(2):267-75
references.pmid: 10918155
references.citation: J Gastroenterol Hepatol. 2015 Jan;30(1):82-5
references.pmid: 25088563
references.citation: Br J Surg. 1999 Mar;86(3):332-7
references.pmid: 10201774
references.citation: N Engl J Med. 2004 Jul 22;351(4):337-45
references.pmid: 15269313
references.citation: Dig Liver Dis. 2014 Sep;46(9):854-8
references.pmid: 24908575
references.citation: Cancer. 1996 Apr 1;77(7):1254-62
references.pmid: 8608500
references.citation: Anticancer Res. 2012 Dec;32(12):5183-91
references.pmid: 23225415
references.citation: World J Surg. 2002 Sep;26(9):1122-5
references.pmid: 12209241
references.citation: Eur J Surg Oncol. 2014 Feb;40(2):234-9
references.pmid: 24295727
references.citation: Histopathology. 2013 Aug;63(2):149-56
references.pmid: 23763641
references.citation: Oncologist. 2007 Jul;12(7):825-39
references.pmid: 17673614
references.citation: J Cancer Res Clin Oncol. 2001;127(3):193-9
references.pmid: 11260865
references.citation: Mod Pathol. 2014 Dec;27(12):1641-8
references.pmid: 24851832
references.citation: Asian J Surg. 2009 Oct;32(4):189-97
references.pmid: 19892621
references.citation: Br J Surg. 2004 Mar;91(3):327-33
references.pmid: 14991634
references.citation: Histopathology. 2014 Jan;64(2):315-6
references.pmid: 24330151
references.citation: N Engl J Med. 2009 Apr 2;360(14):1408-17
references.pmid: 19339720
references.citation: J Pathol. 2001 Oct;195(3):336-42
references.pmid: 11673831
references.citation: Colorectal Dis. 2010 Oct;12(10 Online):e229-35
references.pmid: 19912286
references.citation: Br J Cancer. 2010 Jul 13;103(2):159-64
references.pmid: 20551951
references.citation: Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21
references.pmid: 10493478
references.citation: Gut. 2010 Oct;59(10):1383-8
references.pmid: 20732912
references.citation: J Oncol. 2012;2012:907971
references.pmid: 22919385
references.citation: Clin Exp Metastasis. 2013 Apr;30(4):457-70
references.pmid: 23180209